4.7 Article

Validating γ Oscillations and Delayed Auditory Responses as Translational Biomarkers of Autism

期刊

BIOLOGICAL PSYCHIATRY
卷 68, 期 12, 页码 1100-1106

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2010.09.031

关键词

Animal model; autism; electrophysiology; endophenotype; gamma oscillations; magnetoencephalography (MEG)

资金

  1. National Institutes of Health [R01-DA023210, T32-MH017168, R01-DC008871]
  2. Nancy Lurie Marks Family Foundation
  3. Autism Speaks
  4. Eli Lilly
  5. AstraZeneca
  6. NuPathe
  7. Pfizer
  8. Merck
  9. Sanofi
  10. Wyeth

向作者/读者索取更多资源

Background: Difficulty modeling complex behavioral phenotypes in rodents (e.g., language) has hindered pathophysiological investigation and treatment development for autism spectrum disorders. Recent human neuroimaging studies, however, have identified functional biomarkers that can be more directly related to the abnormal neural dynamics of autism spectrum disorders. This study assessed the translational potential of auditory evoked-response endophenotypes of autism in parallel mouse and human studies of autism. Methods: Whole-cortex magnetoencephalography was recorded in 17 typically developing and 25 autistic children during auditory pure-tone presentation. Superior temporal gyrus activity was analyzed in time and frequency domains. Auditory evoked potentials were recorded in mice prenatally exposed to valproic acid (VPA) and analyzed with analogous methods. Results: The VPA-exposed mice demonstrated selective behavioral alterations related to autism, including reduced social interactions and ultrasonic vocalizations, increased repetitive self-grooming, and prepulse inhibition deficits. Autistic subjects and VPA-exposed mice showed a similar 10% latency delay in the N1/M100 evoked response and a reduction in gamma frequency (30-50 Hz) phase-locking factor. Electrophysiological measures were associated with mouse behavioral deficits. In mice, gamma phase-locking factor was correlated with expression of the autism risk gene neuroligin-3 and neural deficits were modulated by the mGluR5-receptor antagonist MPEP. Conclusions: Results demonstrate a novel preclinical approach toward mechanistic understanding and treatment development for autism.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据